Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by X.-X. Cui
Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Related publications
Enhanced Sensitivity to Androgen Withdrawal Due to Overexpression of Interleukin-6 in Androgen-Dependent Human Prostate Cancer LNCaP Cells
British Journal of Cancer
Cancer Research
Oncology
Androgen Upregulates the Palmitoylation of eIF3L in Human Prostate LNCaP Cells
OncoTargets and Therapy
Oncology
Pharmacology
Dysregulated Expression of Androgen-Responsive and Nonresponsive Genes in the Androgen-Independent Prostate Cancer Xenograft Model, CWR22-R
Nature Genetics
Genetics
Epidermal Growth Factor Receptor (ErbB1) Expression in Prostate Cancer Progression: Correlation With Androgen Independence
Prostate
Oncology
Urology
The Radiation Response of Androgen-Refractory Prostate Cancer Cell Line C4-2 Derived From Androgen-Sensitive Cell Line LNCaP
Asian Journal of Andrology
Medicine
Urology
5α-Reductase Inhibition Coupled With Short Off Cycles Increases Survival in the LNCaP Xenograft Prostate Tumor Model on Intermittent Androgen Deprivation Therapy
Journal of Urology
Urology
Tea Polyphenols Down-Regulate the Expression of the Androgen Receptor in LNCaP Prostate Cancer Cells
Oncogene
Cancer Research
Genetics
Molecular Biology
Mathematical Modeling of Prostate Cancer Progression in Response to Androgen Ablation Therapy
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Silymarin Inhibits Function of the Androgen Receptor by Reducing Nuclear Localization of the Receptor in the Human Prostate Cancer Cell Line LNCaP
Carcinogenesis
Medicine
Cancer Research
